05/09/2024
5:58 PM | Amgen (Issuer)
Bradway Robert A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
5:59 PM | Amgen (Issuer)
Bradner James E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:00 PM | Amgen (Issuer)
Busch Matthew C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:02 PM | Amgen (Issuer)
Gordon Murdo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:03 PM | Amgen (Issuer)
Graham Jonathan P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:04 PM | Amgen (Issuer)
Griffith Peter H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:05 PM | Amgen (Issuer)
Grygiel Nancy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
05/09/2024
6:06 PM | Amgen (Issuer)
Khosla Rachna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:07 PM | Amgen (Issuer)
Miller Derek (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:07 PM | Amgen (Issuer)
REESE DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:08 PM | Amgen (Issuer)
Santos Esteban (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
6:56 PM | Amgen (Issuer)
Drake Michael V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
6:57 PM | Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
6:58 PM | Amgen (Issuer)
ISHRAK OMAR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:30 PM | Amgen (Issuer)
Bradway Robert A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:31 PM | Amgen (Issuer)
Busch Matthew C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:32 PM | Amgen (Issuer)
Gordon Murdo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:33 PM | Amgen (Issuer)
Graham Jonathan P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:34 PM | Amgen (Issuer)
Griffith Peter H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:35 PM | Amgen (Issuer)
Grygiel Nancy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:36 PM | Amgen (Issuer)
Khosla Rachna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:36 PM | Amgen (Issuer)
Miller Derek (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:37 PM | Amgen (Issuer)
REESE DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:39 PM | Amgen (Issuer)
Santos Esteban (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
7:23 PM | Amgen (Issuer)
Bradway Robert A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
7:24 PM | Amgen (Issuer)
Busch Matthew C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
7:25 PM | Amgen (Issuer)
Khosla Rachna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:48 PM | Amgen (Issuer)
Grygiel Nancy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:17 PM | Amgen (Subject)
Grygiel Nancy A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/03/2024
6:18 PM | Amgen (Issuer)
Gordon Murdo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:19 PM | Amgen (Issuer)
Graham Jonathan P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:20 PM | Amgen (Issuer)
Griffith Peter H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:22 PM | Amgen (Issuer)
Grygiel Nancy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:23 PM | Amgen (Issuer)
Miller Derek (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:24 PM | Amgen (Issuer)
REESE DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:25 PM | Amgen (Issuer)
Santos Esteban (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
6:59 PM | Amgen (Issuer)
Graham Jonathan P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
7:00 PM | Amgen (Issuer)
Khosla Rachna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
7:01 PM | Amgen (Issuer)
Miller Derek (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
7:44 PM | Amgen (Issuer)
Grygiel Nancy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
6:50 PM | Amgen (Issuer)
Bradway Robert A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
LEAKED: Jeff Bezos' $330 Million Gamble (Ad) Did you know that 3 simple words are disrupting a $62.7 billion market?
"Blood Brain Barrier"
Seems innocent enough. Here's how you could invest alongside them >>> |
05/01/2024
6:50 PM | Amgen (Issuer)
Busch Matthew C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
6:51 PM | Amgen (Issuer)
Gordon Murdo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
6:53 PM | Amgen (Issuer)
Griffith Peter H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
6:54 PM | Amgen (Issuer)
REESE DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
6:55 PM | Amgen (Issuer)
Santos Esteban (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
7:04 PM | Amgen (Issuer)
Graham Jonathan P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
7:05 PM | Amgen (Issuer)
Griffith Peter H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
7:07 PM | Amgen (Issuer)
Grygiel Nancy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
7:09 PM | Amgen (Issuer)
Khosla Rachna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
7:10 PM | Amgen (Issuer)
Miller Derek (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
7:11 PM | Amgen (Issuer)
REESE DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
7:12 PM | Amgen (Issuer)
Santos Esteban (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
6:58 PM | Amgen (Issuer)
Bradway Robert A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
6:59 PM | Amgen (Issuer)
Busch Matthew C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
7:00 PM | Amgen (Issuer)
Gordon Murdo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:34 PM | Amgen (Issuer)
Santos Esteban (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:24 PM | Amgen (Issuer)
Busch Matthew C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:25 PM | Amgen (Issuer)
Gordon Murdo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:26 PM | Amgen (Issuer)
Graham Jonathan P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:27 PM | Amgen (Issuer)
Griffith Peter H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:29 PM | Amgen (Issuer)
Grygiel Nancy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:30 PM | Amgen (Issuer)
Khosla Rachna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:31 PM | Amgen (Issuer)
Miller Derek (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:32 PM | Amgen (Issuer)
REESE DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:23 PM | Amgen (Issuer)
Bradway Robert A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
3:23 PM | Amgen (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/12/2024
6:50 PM | Amgen (Issuer)
Bradner James E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
10:35 AM | Amgen (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
12/19/2023
7:38 PM | Amgen (Issuer)
Bradner James E. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/14/2023
8:16 AM | Amgen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2023
6:40 PM | Amgen (Subject)
Grygiel Nancy A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/04/2023
6:41 PM | Amgen (Issuer)
Grygiel Nancy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2023
7:44 PM | Amgen (Issuer)
REESE DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
7:30 PM | Amgen (Issuer)
Graham Jonathan P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2023
1:11 PM | Amgen (Subject)
Graham Jonathan P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2023
7:06 PM | Amgen (Issuer)
Drake Michael V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
7:09 PM | Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
7:10 PM | Amgen (Issuer)
ISHRAK OMAR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
7:12 PM | Amgen (Issuer)
Busch Matthew C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
7:15 PM | Amgen (Issuer)
Grygiel Nancy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
7:16 PM | Amgen (Issuer)
Khosla Rachna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
7:20 PM | Amgen (Issuer)
Miller Derek (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
6:43 PM | Amgen (Issuer)
Graham Jonathan P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
6:44 PM | Amgen (Issuer)
Griffith Peter H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
6:15 AM | Amgen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/06/2023
3:35 PM | Amgen (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
10/05/2023
6:43 AM | Amgen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2023
6:30 AM | Amgen (Filed by)
Neumora Therapeutics, Inc. (Subject)
| Form SC 13D | |
09/19/2023
6:52 PM | Amgen (Reporting)
Neumora Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2023
5:58 PM | Amgen (Reporting)
Neumora Therapeutics, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
Warren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector… (Ad) Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Congress shifting their stocks in a frenzy?
And why are they all piling into ONE unique corner of the market… Click here for the details |
09/12/2023
6:30 AM | Amgen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2023
8:12 AM | Amgen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/01/2023
8:25 AM | Amgen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/21/2023
6:36 PM | Amgen (Issuer)
Busch Matthew C. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/11/2023
5:13 PM | Amgen (Issuer)
Gordon Murdo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/10/2023
7:55 PM | Amgen (Issuer)
Drake Michael V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/10/2023
7:56 PM | Amgen (Issuer)
ISHRAK OMAR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/10/2023
7:57 PM | Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/10/2023
2:18 PM | Amgen (Subject)
Gordon Murdo (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
